Nelson et al., 2023 - Google Patents

Synthetic 5-amino-6-D-ribitylaminouracil paired with inflammatory stimuli facilitates MAIT cell expansion in vivo

Nelson et al., 2023

View HTML
Document ID
12654429400491319948
Author
Nelson A
Wang H
Dewar P
Eddy E
Li S
Lim X
Patton T
Zhou Y
Pediongco T
Meehan L
Meehan B
Mak J
Fairlie D
Stent A
Kjer-Nielsen L
McCluskey J
Eckle S
Corbett A
Souter M
Chen Z
Publication year
Publication venue
Frontiers in Immunology

External Links

Snippet

Introduction Mucosal-associated invariant T (MAIT) cells are a population of innate-like T cells, which mediate host immunity to microbial infection by recognizing metabolite antigens derived from microbial riboflavin synthesis presented by the MHC-I-related protein 1 (MR1) …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Mikhak et al. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4
Welsh et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody
Sheridan et al. Oral infection drives a distinct population of intestinal resident memory CD8+ T cells with enhanced protective function
Barao et al. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+ CD25+ regulatory T cells
Hänninen et al. Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes
Schatton et al. ABCB5 identifies immunoregulatory dermal cells
Xiao et al. Mucosal-associated invariant T cells: new insights into antigen recognition and activation
Kotner et al. Endogenous CD4+ CD25+ regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice
Machado et al. Pathogenesis of Chagas disease: time to move on
Sawamukai et al. Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD
Hu et al. In vitro priming of adoptively transferred T cells with a RORγ agonist confers durable memory and stemness in vivo
Courtney et al. Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung
Cui et al. Immunotherapy of established tumors using bone marrow transplantation with antigen gene–modified hematopoietic stem cells
Luyendyk et al. Antigen-presenting cell function during Plasmodium yoelii infection
US20140370038A1 (en) Cd4+ cd25+ t-cells activated to a specific antigen
Neyt et al. Double-negative T resident memory cells of the lung react to influenza virus infection via CD11chi dendritic cells
Yu et al. Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines
Kong et al. Tissue-resident PSGL1 lo CD4+ T cells promote B cell differentiation and chronic graft-versus-host disease–associated autoimmunity
Zimara et al. Langerhans cells promote early germinal center formation in response to Leishmania‐derived cutaneous antigens
Tha-In et al. Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+ Foxp3+ T cells
CN103402541A (en) Enhancement of allogeneic hematopoietic stem cell transplantation
Li et al. Modulation of immune checkpoints and graft-versus-leukemia in allogeneic transplants by antagonizing vasoactive intestinal peptide signaling
Jing et al. T cells deficient in diacylglycerol kinase ζ are resistant to PD-1 inhibition and help create persistent host immunity to leukemia
Chen et al. Characterization and purification of mouse mucosal‐associated invariant T (MAIT) cells
Fousteri et al. Increased memory conversion of naive CD8 T cells activated during late phases of acute virus infection due to decreased cumulative antigen exposure